In response to RFA-DK-09-504 we present a plan for future activities of the Coordinating Center for the Beta Cell Biology Consortium (BCBC). This consortium, which was initially launched in September 2001 then renewed in 2005, brings a team-oriented approach to studies necessary to learn how to regenerate or replace pancreatic beta cells that are either destroyed or damaged by Type 1 or Type 2 diabetes. The Coordinating Center plays a vital role in the consortium by 1) organizing investigator meetings and retreats, 2) maintaining the BCBC website and reagent databases, 3) overseeing BCBC core facilities, 4) providing advanced bio/informatics applications, 5) managing special funding programs, 6) providing various types of administrative support, and 7) facilitating interactions with other NIH-sponsored Centers and Consortia. During the next cycle of the BCBC the Coordinating Center will 1) continue to perform many ongoing operations, 2) adapt to changes in the scientific focus and new participants, and 3) improve the website in a way to facilitate team science and sharing of unpublished knowledge and reagents.

Public Health Relevance

Type 1 and Type 2 diabetes cause significant morbidity and mortality and thus have an adverse economic impact. Both diseases are characterized by the destruction or dysfunction of insulin-secreting pancreatic beta cells. This application will coordinate activities among a team of scientists in order to develop new, cell-based replacement therapies that hold promise for achieving better glucose control than is currently possible.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01DK072473-09
Application #
8525392
Study Section
Special Emphasis Panel (ZDK1-GRB-G (M3))
Program Officer
Sato, Sheryl M
Project Start
2005-08-01
Project End
2015-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
9
Fiscal Year
2013
Total Cost
$3,570,015
Indirect Cost
$526,549
Name
Vanderbilt University Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Brissova, Marcela; Aamodt, Kristie; Brahmachary, Priyanka et al. (2014) Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes ? cell regeneration. Cell Metab 19:498-511
Montague, Elizabeth; Stanberry, Larissa; Higdon, Roger et al. (2014) MOPED 2.5--an integrated multi-omics resource: multi-omics profiling expression database now includes transcriptomics data. OMICS 18:335-43
Seto, Yusuke; Nakatani, Tomoya; Masuyama, Norihisa et al. (2014) Temporal identity transition from Purkinje cell progenitors to GABAergic interneuron progenitors in the cerebellum. Nat Commun 5:3337
Chahal, Jasleen K; Wong, Victor S C; Chaboissier, Marie-Christine et al. (2014) R-spondin1 deficiency enhances *-Cell neogenesis in a murine model of diabetes. Pancreas 43:93-102
Higdon, Roger; Stewart, Elizabeth; Stanberry, Larissa et al. (2014) MOPED enables discoveries through consistently processed proteomics data. J Proteome Res 13:107-13
Hang, Yan; Yamamoto, Tsunehiko; Benninger, Richard K P et al. (2014) The MafA transcription factor becomes essential to islet ?-cells soon after birth. Diabetes 63:1994-2005
Stanberry, Larissa; Rekepalli, Bhanu; Liu, Yuan et al. (2014) Optimizing high performance computing workflow for protein functional annotation. Concurr Comput 26:2112-2121
Stewart, Morag H; Gutierrez-Martinez, Paula; Beerman, Isabel et al. (2014) Growth hormone receptor signaling is dispensable for HSC function and aging. Blood 124:3076-80
Worchel, Hannah N; Magnuson, Mark A (2014) Cytokine-driven beta-cell production in vivo. Nat Biotechnol 32:63-4
Beerman, Isabel; Seita, Jun; Inlay, Matthew A et al. (2014) Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell 15:37-50

Showing the most recent 10 out of 41 publications